Search Results 61-70 of 17235 for peptide protocols

  1. A Study To Test The Effect Of BI 456906 On Cardiovascular Safety In People With Overweight Or Obesity (SYNCHRONIZE™ - CVOT) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. A Study of Nighttime Blood Sugar Control Patterns in Type 2 Diabetes - Mayo Clinic

    Sponsor Protocol Number: 13-009661 ... Guidelines differ from study to study, and ... Diabetics on insulin, glucagon-like peptide-1 based therapies or ...

  3. Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes In Heart Failure - Mayo Clinic

    Sponsor Protocol Number: 13-005779 ... Guidelines differ from study to study, and identify who can or cannot participate. ... a plasma B-type Natriuretic Peptide ( ...

  4. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability profile of JK07, administered intravenously, according to protocol-defined dosing regimen.

  5. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure - Mayo Clinic

    Sponsor Protocol Number: 19-006517 ... Guidelines differ from study to study, and identify who can or cannot participate. ... peptide (NP) system. We measured ...

  6. Biomarkers in Aortic Stenosis - B.A.S.S. - Mayo Clinic

    Sponsor Protocol Number: 09-006757 ... peptide (BNP) levels. The results of the blood ... Guidelines differ from study to study, and identify who can or cannot ...

  7. VTP-1000 in celiac disease - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Clinical trials - Oncology (Medical)

    ... peptide administered in combination with pembrolizumab to patients with advanced solid tumors. ... Protocol of TheraSphere for Treatment of Unresectable Primary ...

  9. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    Sponsor Protocol Number: 17-007596 ... Guidelines differ from study to study, and identify who can or cannot participate. ... peptide (NT-proBNP) would identify a ...